- Issuer ticker
-
ANVS
- Reported as of
-
10 Sep 2025
- Net transaction value
-
+$1,000
Source evidence
Original filing metadata and source links for verification.
4 source fields
- SEC form
-
4
- Accepted by SEC
-
12 Nov 2025, 09:17:18 UTC
Reporting owner
1 detail
- Reporting owner signature
-
/s/ Claudine Bruck
Key filing fact
Claudine Bruck filed Form 4 for Annovis Bio, Inc. (ANVS) on 12 Nov 2025.
Key facts
- This page summarizes Claudine Bruck's Form 4 filing for Annovis Bio, Inc. (ANVS).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 12 Nov 2025, 09:17.
Change
- Previous filing in this sequence was filed on 22 Nov 2023.
- Current net transaction value: +$1,000.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
Ownership activity is grounded in SEC Form 4 disclosures.
View source filing
Reporting Owners (1)
CIK 0001733680
Primary reporting owner
Bruck Claudine
- Relationship
-
Director
- Address
- C/O ANNOVIS BIO, INC., 101 LINDENWOOD DR, SUITE 225, MALVERN
- Signature
- /s/ Claudine Bruck
- Signature date
- 12 Nov 2025
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
ANVS
transaction
Common Stock
Options Exercise
- Transaction value
- $1,000
- Shares
- +7,142
- Change %
- +109%
- Price
-
$0.1400
- Shares after
- 13,709
- Date
- 10 Sep 2025
- Ownership
- Direct
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
ANVS
transaction
Derivative
Option
Options Exercise
- Transaction value
- $0
- Shares
- -7,142
- Change %
- -100%
- Price
-
$0.000000
- Shares after
- 0
- Date
- 10 Sep 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 7,142
- Exercise price
- $0.1400
* marks a reported price that did not pass the local price check.